Literature DB >> 5151304

Evaluation of a sustained release form of the oral antidiabetic butylbiguanide (Silubin retard).

R Beckmann, W Lintz, E Schmidt-Böthelt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5151304     DOI： 10.1007/BF00565010

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  17 in total

1.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1964-11       Impact factor: 3.534

2.  A METHOD FOR BETA COUNTING OF LARGE SAMPLES OF PLASMA BY LIQUID SCINTILLATION.

Authors:  P M BLOOM; W B NELP
Journal:  J Lab Clin Med       Date:  1965-06

3.  Direct proportionality of urinary excretion rate and serum level of tetracycline in human subjects.

Authors:  T CHULSKI; R H JOHNSON; C A SCHLAGEL; J G WAGNER
Journal:  Nature       Date:  1963-05-04       Impact factor: 49.962

4.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

5.  Distribution of n-butylbiguanide-14C hydrochloride in mouse tissues.

Authors:  Y J Yoh
Journal:  Jpn J Pharmacol       Date:  1967-09

6.  [Absorption, distribution in the organism and elimination of metformin].

Authors:  R Beckmann
Journal:  Diabetologia       Date:  1969-10       Impact factor: 10.122

7.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

8.  Equations for excretion rate and renal clearances of exogenous substances not actively reabsorbed.

Authors:  J G Wagner
Journal:  J Clin Pharmacol J New Drugs       Date:  1967 Mar-Apr

9.  [On the pharmacokinetics of 1-butyl-biguanide hydrochloride and the prolonged-action form of this substance].

Authors:  R Beckmann; G Hübner
Journal:  Arzneimittelforschung       Date:  1965-07

10.  [A contribution to the method of determination of biguanides, creatinine and creatine in the urine].

Authors:  H Haller; S E Strauzenberg
Journal:  Arztl Forsch       Date:  1966-08-10
View more
  5 in total

1.  Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man.

Authors:  W Lintz; W Berger; W Aenishaenslin; V Kutova; C Baerlocher; J P Kapp; R Beckmann
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

2.  Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.

Authors:  Zongjian Zhu; Weiqin Jiang; Matthew D Thompson; Dimas Echeverria; John N McGinley; Henry J Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2015-03-24

Review 3.  The Mechanism of Action of Biguanides: New Answers to a Complex Question.

Authors:  Laura Di Magno; Fiorella Di Pastena; Rosa Bordone; Sonia Coni; Gianluca Canettieri
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

4.  Buformin concentrations in a case of fatal lactic acidosis.

Authors:  L F Verdonck; B Sangster; A N van Heijst; G de Groot; R A Maes
Journal:  Diabetologia       Date:  1981       Impact factor: 10.122

Review 5.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.